Envoy Medical, Inc.
corporate_fare Company Profile
Envoy Medical, Inc. (NASDAQ:COCH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 32 items for COCH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-31, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for COCH spans DEF 14A, PRE 14A, 8-K, 10-Q.
Recent high-impact activity:
- Envoy Medical Sets October 12 Vote on 1-for-5 to 1-for-25 Reverse Split to Avoid Nasdaq Delisting
- Envoy Medical Seeks Shareholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
- Envoy Medical Reports Q2 2026 Results, Submits First PMA Module to FDA, and Posts Positive 12-Month Trial Data
- Envoy Medical Q2 2026: Cash Runway Through Q1 2027, Going Concern Doubt Persists
- Envoy Medical Hits Key Trial Milestone: All 56 Patients Pass 3-Month Mark
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for COCH, detected from its recent SEC filings · based on capital-structure filings through 2026-03-23.
Critical Warrant Approval Sought · Significant Equity Plan Dilution Proposed
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →